Ellen Snyder

4.1k citations

50 papers · 2.9k indexed · 2 hit papers · h-index 24

Impact in

Endocrine and Autonomic Systems top 0.5%
- Circadian rhythm and melatonin
Experimental and Cognitive Psychology top 1%
- Sleep and related disorders

Papers in ⓘ

Experimental and Cognitive Psychology 26
- Sleep and related disorders 26
Endocrine and Autonomic Systems 12
- Circadian rhythm and melatonin 11

Co-authors: W. Joseph Herring (23 shared papers)Christopher Lines (17 shared papers)David Michelson (12 shared papers)Jill Hutzelmann (14 shared papers)Thomas Roth (11 shared papers)Duane Snavely (9 shared papers)Ingrid Adamsons (4 shared papers)Mary F. Morrison (1 shared paper)
Journals: SLEEP (6 papers)Sleep Medicine (5 papers)Journal of Sleep Research (3 papers)Neurology (3 papers)Ophthalmology (3 papers)
Partner nations: United States Italy Canada

In The Last Decade

Ellen Snyder

49 papers receiving 2.8k citations

Hit Papers

align trajectories log scale

A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression 2018 · 276 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2018 Journal of Clinical Sleep Medicine
2016 Journal of Clinical Oncology

Peers

Countries citing papers authored by Ellen Snyder

Since Specialization

Citations

This map shows the geographic impact of Ellen Snyder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Snyder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Snyder more than expected).

Fields of papers citing papers by Ellen Snyder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Snyder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Snyder. The network helps show where Ellen Snyder may publish in the future.

Co-authors

The 25 scholars most cited alongside Ellen Snyder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ellen Snyder Line = papers co-authored together Ellen Snyder links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Programmed Death-1 Blockade With Pembrolizumab in Patients With Classical Hodgkin Lymphoma After Brentuximab Vedotin Failure Journal of Clinical Oncology ·Philippe Armand, Margaret A. Shipp, Vincent Ribrag, Jean‐Marie Michot, Pier Luigi Zinzani, John Kuruvilla, Ellen Snyder, Alejandro D. Ricart, Arun Balakumaran, Shelonitda Rose, Craig H. Moskowitz Hit paper breakdown →	2016	477
2	A New Single-Item Sleep Quality Scale: Results of Psychometric Evaluation in Patients With Chronic Primary Insomnia and Depression Journal of Clinical Sleep Medicine ·Ellen Snyder, Bing Cai, Carla DeMuro, Mary F. Morrison, William A. Ball Hit paper breakdown →	2018	276
3	Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial The Lancet Neurology ·David Michelson, Ellen Snyder, Erin M. Paradis, Mary Chengan-Liu, Duane Snavely, Jill Hutzelmann, James K. Walsh, Andrew D. Krystal, Ruth M. Benca, Martin A. Cohn, Christopher Lines, Thomas Roth, W. Joseph Herring	2014	254
4	Orexin receptor antagonism for treatment of insomnia Neurology ·W. Joseph Herring, Ellen Snyder, Kerry Budd, Jill Hutzelmann, Duane Snavely, Kenneth Liu, Christopher Lines, Thomas Roth, David Michelson	2012	245
5	A Cohort Study of Transcutaneous Oxygen Tension and the Incidence and Severity of Retinopathy of Prematurity New England Journal of Medicine ·John T. Flynn, Eduardo Bancalari, Ellen Snyder, Ronald N. Goldberg, William J. Feuer, Janet Cassady, Joyce Schiffman, Harold I. Feldman, Brian Baghynski, Edward Buckley, Jacqueline Roberts, Dennis B. Gillings	1992	231
6	Suvorexant in Patients With Insomnia: Results From Two 3-Month Randomized Controlled Clinical Trials Biological Psychiatry ·W. Joseph Herring, Kathryn M. Connor, Neely Ivgy-May, Ellen Snyder, Ken Liu, Duane Snavely, Andrew D. Krystal, James K. Walsh, Ruth M. Benca, Russell Rosenberg, R. Bart Sangal, Kerry Budd, Jill Hutzelmann, Heather Leibensperger, Samar Froman, Christopher Lines, Thomas Roth, David Michelson	2014	216
7	Polysomnographic assessment of suvorexant in patients with probable Alzheimer's disease dementia and insomnia: a randomized trial Alzheimer s & Dementia ·W. Joseph Herring, Paulette Ceesay, Ellen Snyder, Donald L. Bliwise, Kerry Budd, Jill Hutzelmann, Joanne Stevens, Christopher Lines, David Michelson	2020	129
8	A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide 11Ms. Clineschmidt, Dr. Adamsons, Dr. Snyder, and Dr. Reines are employees of Merck & Co., Inc., the manufacturer of the dorzolamide-timolol combination. The other authors have no proprietary interest in the dorzolamide-timolol combination or in Merck. Ophthalmology ·Coleen M. Clineschmidt, Robert Williams, Ellen Snyder, Ingrid Adamsons	1998	120
9	The efficacy and safety of the Dorzolamide—timolol combination versus the concomitant administration of its components11Ms. Strohmaier and Drs. Snyder and Adamsons are employees of Merck & Co., Inc, the manufacturer of the dorzolamide-timolol combination. Dr. DuBiner has no proprietary interest in the dorzolamide-timolol combination or Merck. Ophthalmology ·Kim M. Strohmaier, Ellen Snyder, Harvey Dubiner, Ingrid Adamsons	1998	108
10	Using a claims database to investigate drug‐induced Stevens‐Johnson syndrome Statistics in Medicine ·Brian L. Strom, Jeffrey L. Carson, Allan C. Halpern, Rita Schinnar, Ellen Snyder, Paul D. Stolley, Michele R. Shaw, Hugh H. Tilson, Michael Joseph, Wanju S. Dai, Diane Chen, Robert S. Stern, Ulf Bergman, Frank E. Lundin	1991	63
11	Suvorexant in Patients with Insomnia: Pooled Analyses of Three-Month Data from Phase-3 Randomized Controlled Clinical Trials Journal of Clinical Sleep Medicine ·W. Joseph Herring, Kathleen M. Connor, Ellen Snyder, Duane Snavely, Ying Zhang, Jill Hutzelmann, Deborah Matzura‐Wolfe, Ruth M. Benca, Andrew D. Krystal, James K. Walsh, Christopher Lines, Thomas Roth, David Michelson	2016	63
12	Effects of suvorexant on sleep architecture and power spectral profile in patients with insomnia: analysis of pooled phase 3 data Sleep Medicine ·Ellen Snyder, Junshui Ma, Vladimir Svetnik, Kathryn M. Connor, Christopher Lines, David Michelson, W. Joseph Herring	2015	56
13	Suvorexant in Elderly Patients with Insomnia: Pooled Analyses of Data from Phase III Randomized Controlled Clinical Trials American Journal of Geriatric Psychiatry ·W. Joseph Herring, (unknown), Ellen Snyder, (unknown), (unknown), Jill Hutzelmann, Deborah Matzura‐Wolfe, Ruth M. Benca, Andrew D. Krystal, Jared P. Walsh, Christopher L. Drake, Thomas Roth, David Michelson	2017	48
14	Shingles, Allergies, Family Medical History, Oral Contraceptives, and Other Potential Risk Factors for Systemic Lupus Erythematosus American Journal of Epidemiology ·Brian L. Strom, Marcus M. Reidenberg, Suzanne L. West, Ellen Snyder, Bruce Freundlich, Paul D. Stolley	1994	48
15	EEG spectral analysis of NREM sleep in a large sample of patients with insomnia and good sleepers: effects of age, sex and part of the night Journal of Sleep Research ·Vladimir Svetnik, Ellen Snyder, Junshui Ma, Peining Tao, Christopher Lines, W. Joseph Herring	2016	46
16	Immunogenicity of pembrolizumab in patients with advanced tumors Journal for ImmunoTherapy of Cancer ·Marianne J.H. van Vugt, Julie A. Stone, “Rik” H. J. M. M. De Greef, Ellen Snyder, Leslie Lipka, David C. Turner, Anne Chain, Mallika Lala, Mengyao Li, Seth Robey, Anna Kondic, Dinesh de Alwis, Kapil Mayawala, Lokesh Jain, Tomoko Freshwater	2019	44
17	Electroencephalographic Power Spectral Density Profile of the Orexin Receptor Antagonist Suvorexant in Patients with Primary Insomnia and Healthy Subjects SLEEP ·Junshui Ma, Vladimir Svetnik, Ellen Snyder, Christopher Lines, Thomas Roth, W. Joseph Herring	2014	43
18	Slow Wave Sleep Enhancement with Gaboxadol Reduces Daytime Sleepiness During Sleep Restriction SLEEP ·James K. Walsh, Ellen Snyder, Janine Hall, Angela C. Randazzo, Kara Griffin, John A. Groeger, Rhody D. Eisenstein, Stephen D. Feren, Pam Dickey, Paula K. Schweitzer	2008	42
19	A Phase II Dose-Ranging Study Evaluating the Efficacy and Safety of the Orexin Receptor Antagonist Filorexant (MK-6096) in Patients with Primary Insomnia The International Journal of Neuropsychopharmacology ·Kathryn M. Connor, Erin Mahoney, Saheeda Jackson, Jill Hutzelmann, Xin Zhao, Nan Jia, Ellen Snyder, Duane Snavely, David Michelson, Thomas Roth, W. Joseph Herring	2016	36
20	PD-1 Blockade with Pembrolizumab in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Safety, Efficacy, and Biomarker Assessment Blood ·Philippe Armand, Margaret A. Shipp, Vincent Ribrag, Jean‐Marie Michot, Pier Luigi Zinzani, Martin Gutierrez, Ellen Snyder, Alejandro D. Ricart, Arun Balakumaran, Craig H. Moskowitz	2015	28

About Ellen Snyder

Ellen Snyder is a scholar working on Experimental and Cognitive Psychology, Endocrine and Autonomic Systems, Cognitive Neuroscience, Toxicology and Ophthalmology, having authored 50 papers that have together received 2.9k indexed citations. Recurring topics across this work include Sleep and related disorders (26 papers), Sleep and Wakefulness Research (26 papers), Circadian rhythm and melatonin (11 papers), Restless Legs Syndrome Research (6 papers), Glaucoma and retinal disorders (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Ophthalmology and Eye Disorders (4 papers) and CAR-T cell therapy research (3 papers). The work is most often cited by research in Endocrine and Autonomic Systems (815 citations), Experimental and Cognitive Psychology (1.2k citations), Cognitive Neuroscience (1.2k citations), Ophthalmology (274 citations) and Pathology and Forensic Medicine (431 citations). Ellen Snyder has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include W. Joseph Herring, Christopher Lines, David Michelson, Jill Hutzelmann, Thomas Roth, Duane Snavely, Ingrid Adamsons, Mary F. Morrison, Carla DeMuro and William A. Ball. Their work appears in journals such as SLEEP, Sleep Medicine, Journal of Sleep Research, Neurology and Ophthalmology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact